Clinical Trials

At Comprehensive Urologic Care we are committed to ongoing research and development for better knowledge, care, and therapy in urologic medicine. That’s why we participate in ongoing clinical research studies which help determine which treatments and medicines are more effective than others.

Patients take part in clinical trials for many reasons. They may hope for a cure to a disease, a longer time to live, or a way to feel better. And some patients want to contribute to a research effort that may help others.

Because CUC participates in clinical trials, our patients have the distinct advantage of access to advanced treatments years before they might become available to the general public.

If you would like to participate in one of our studies, please talk to your physician.

Current Clinical Trials

Overactive Bladder (OAB) - Axonics

Recruiting both female and male patients with overactive bladder symptoms to assess the use of a new imaging technique in the initial evaluation for sacral nerve stimulation.

Patients may be eligible if:

18 or over
Have symptoms of overactive bladder, urinary retention, and/or fecal incontinence
You are eligible to be implanted with the Axonics Sacral Neuromodulation (SNM) device.

More information is available here: Sacral Neuromodulation Therapy & Treatment Details | Axonics®

For more details on selection criteria and treatment, please contact our clinical trials team today.

Cancer Screening - GH 101

Enrolling patients with a history of cancer to help provide additional genetic testing and to help enhance understanding of DNA variant testing and interpretation.

Patients may be eligible if:

Between the ages of 21 and 85
Present with a history of cancer or is currently diagnosed with cancer
May potentially be enrolled pending insurance verification ( No out of pocket costs to the patient)

More Information is available here: GH101 – Genetic Susceptibility To Chronic Disease – Genetics Institute Of America (genlabus.com)

For more details on selection criteria and treatment, please contact our clinical trials team today.

Metastatic Prostate Cancer – Astra Zeneca EvoPar

A Clinical study looking at whether a new experimental treatment can help men with a certain type of prostate cancer

Patients may eligible if:

You have been diagnosed with prostate cancer
Your prostate cancer can be treated with a certain type of hormone therapy

More information can be found here – Saruparib (AZD5305) vs Placebo in Men with Metastatic Castration-Sensitive Prostate Cancer Receiving Physician’s Choice New Hormonal Agents (astrazenecaclinicaltrials.com)

For more details on selection criteria and treatment, please contact our clinical trials team today.